Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 21, 2025; 31(11): 104170
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.104170
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.104170
Table 1 Tissue biopsy remains the gold standard technique for diagnosis at present
Liquid biopsy | Tissue biopsy |
Advantages | |
Minimally invasive-easy sampling | Histological evaluation |
Serial analysis-tumour evolution monitoring | Clinically validated and standardised |
Ability to assess drug response-drug resistance | Available in most hospitals |
Ability to use for postoperative follow-up/surveillance | Provides a direct sample of tumour tissue, ensuring accurate pathological analysis |
Fast | Facilitates detailed genetic and molecular profiling of the sampled tissue |
Comprehensive tumour profiling | |
Applicable to inaccessible tumours | |
Reveals tumour heterogeneity | |
Lower cost of sample isolations | |
Disadvantages | |
Not clinically validated | Invasive procedure |
No histological evaluation | Not applicable in inaccessible tumours |
Low availability | Localised tissue sampling |
Low sensitivity (may miss low-abundance mutations or those not shed into the bloodstream | No capacity for tumour evolution monitoring, drug response-drug resistance monitoring, tumour heterogeneity assessment |
Technology-dependent | Time intensive procedure |
High costs (in case of NGS and WGS) | Higher cost of sample isolations |
- Citation: Kotsifa E, Saffioti F, Mavroeidis VK. Cholangiocarcinoma: The era of liquid biopsy. World J Gastroenterol 2025; 31(11): 104170
- URL: https://www.wjgnet.com/1007-9327/full/v31/i11/104170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i11.104170